Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Northwestern University
- Study ID
- NCT07290543
- Status
- Recruiting
Conditions
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Educational Intervention — OTHERReceive educational materials on distress management and guides to telehealth
- Educational Intervention — OTHERReceive written educational brochure about distress management
- Internet-Based Intervention — OTHERReceive access to CONNECT platform
- Interview — OTHERComplete interview
- Interview — OTHERComplete small group workshop
- Patient Navigation — BEHAVIORALReceive personalized recommendations for resources
- Survey Administration — OTHERAncillary study
- Telephone-Based Intervention — BEHAVIORALComplete calls with research assistant
- Text Message-Based Navigation Intervention — OTHERReceive text message reminders
Study Details
This clinical trial tests how well a web based toolkit works to improve cancer related emotional distress and anxiety in rural older cancer survivors. Rural older adults with cancer-related distress are particularly vulnerable to poorer mental health and cancer-related outcomes including increased difficulties identifying symptoms of anxiety, a reduced likelihood of knowing when to access mental health services, and a higher likelihood of having poorly managed CRD, even after receiving a psychosocial referral. The web based tool kit called CONNECT addresses digital literacy and supports for cancer-related distress management through interactive activities for setting up telehealth visits, accessing educational materials about cancer-related distress, and providing individualized mental health resource recommendations. Using CONNECT may improve cancer related emotional distress and anxiety in rural older cancer survivors.
Key Dates
- Start date
- Aug 26, 2025
- Status verified
- Dec 2025
- Primary completion
- Aug 26, 2031
- Completion
- Aug 26, 2032
Study Design
- Enrollment
- 578 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm I (Advisory board)Advisory board members complete small group workshops, interviews and surveys on study.
- Experimental: Arm II (CONNECT platform)Patients and their caregivers receive access to the CONNECT platform, which includes educational materials on distress management, guides to telehealth and personalized recommendations for resources. Patients and their caregivers complete a guided tutorial of the platform with a research assistant at the start of the intervention period, receive biweekly phone calls with the research assistant, for 20 minutes starting on 14 days to 2 months to review the four cancer-related management functions and receive a text message reminders to encourage use, every 2 weeks for 4 months.
- Active Comparator: Arm III (Educational brochure)Patients are mailed an educational brochure about distress management on study.
Primary Outcome Measure
Cancer Related Distress (validated 23-item scale) [ Time Frame: Up to 1 year ]
Central Contacts
- Study Coordinator312-503-1986
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern University | Chicago | Illinois | 60611 | Marquita W. Lewis, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chicago, IL
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruiting · National Cancer Institute LAO · Birmingham, Alabama
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid TumorsRecruiting · SWOG Cancer Research Network · Anchorage, Alaska